Medreich PLC

SMEUK · FelthamCompany No. 03122988

Medreich PLC is a UK public limited company (PLC), based in Feltham, incorporated in 1995. Has won 28 UK public-sector contracts worth £18.8m across 5 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£17.8m

▲ 4646% vs prior 12m

Public buyers

stable this month

Top buyer share

100%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 100% of revenue.

NHS England

£18.8m

100%

The NHS Commissioning Board (operating under the name of NHS England)

—

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

—

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)

—

Contracts won · 28 total · 25 active · 2 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS National Framework for Generics Housekeeping	NHS England	Shared contract	£17.8m lot total · 21 suppliers	10 Nov 2025	pending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products	NHS England	Shared contract	£376k lot total · 31 suppliers	16 Apr 2025	active
NHS National Pharmaceuticals - Everolimus and terminated agreement products	NHS England	Shared contract	£301k lot total · 15 suppliers	08 Jun 2021	expired
NHS National Generic Pharmaceuticals Interim 2	NHS England	Shared contract	£242k lot total · 51 suppliers	21 Dec 2020	expired
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)	NHS England	Shared contract	£0.02 lot total · 63 suppliers	04 Mar 2024	active
NHS National Generic Pharmaceuticals Interim 2 2020	The NHS Commissioning Board (operating under the name of NHS England)	Direct contract	—	—	active
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025	NHS England	Direct contract	—	—	active
NHS National Generic Pharmaceuticals Wave 15b	NHS England	Direct contract	—	—	active
NHS National Generic Pharmaceuticals Wave 14c	NHS England	Direct contract	—	—	active
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	Direct contract	—	—	active
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	Direct contract	—	—	active
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	Direct contract	—	—	active
Atropine and Ciprofloxacin 2024-2025	Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency	Direct contract	—	—	active
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 37 suppliers	—	active
NP30923 Psychiatry and Neurology Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 20 suppliers	—	active

Showing 1–15 of 28

Medreich PLC

Buyer concentration

Contracts won · 28 total · 25 active · 2 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Medreich PLC

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive